SavedAdd your journal

Journals / Anestezi Dergisi / 2017 / Cilt: 25 - Sayı: 1

Ergenoğlu: Targeted Temperature Management

KARDİYAK ARREST SONRASI HEDEFE YÖNELİK SICAKLIK YÖNETİMİ

Pınar ERGENOLU
Pages
6–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is suggested that the constant stable temperature should be between 32-36 °C in the use of TTM.Randomised controlled studies on optimal target temperature after the cardiac arrest, optimal timing for the start and optimumtreatment time is still being continued.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Targeted temperature management (TTM) has been used perodically for over the past 100 years.
📊
Key Findings & Data:However, just recently it hasgained its main power in clinical practice.
💡
Conclusion & Impact:It is suggested that the constant stable temperature should be between 32-36 °C in the use of TTM.Randomised controlled studies on optimal target temperature after the cardiac arrest, optimal timing for the start and optimumtreatment time is still being continued.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Targeted temperature management (TTM) has been used perodically for over the past 100 years. However, just recently it hasgained its main power in clinical practice. Clinical indications for TTM for neuroprotective therapy includes postcardiac arrestsyndrome in adult patients. It is suggested that the constant stable temperature should be between 32-36 °C in the use of TTM.Randomised controlled studies on optimal target temperature after the cardiac arrest, optimal timing for the start and optimumtreatment time is still being continued.

Özet

Hedefe yönelik sıcaklık yönetimi (HYSY) 100 yıldan fazla süredir aralıklarla kullanılmaktadır; klinik pratikteki ana rolünüancak son yıllarda kazanmıştır. Nöroprotektif terapi olarak HYSY için klinik endikasyonlar erişkin hastalarda Post-kardiyak arrestsendromunu (PKAS) içermektedir. Sıcaklık kontrolü kullanılacaksa hedef sıcaklığın 32-36 °C arasında sabit olarak sürdürülmesiönerilmektedir. Kardiyak arrest sonrası optimal hedef sıcaklık, başlangıç için optimal zamanlama ve tedavi için optimum tedavisüresi ile ilişkili randomize kontrollü çalışmalar halen devam etmektedir.

🔖

Cite This Article

ERGENOLU, P. (2017). Ergenoğlu: Targeted Temperature Management. Anestezi Dergisi, Cilt: 25 - Sayı: 1, 6–10. https://ajindex.com/articles/355174

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Wang H, Olivero W, Wang D, Lanzino G. Cold as a therapeutic agent. Acta Neurochir (Wien) 2006; 148: 565-570
  2. Varon J, Acosta P. Therapeutic hypothermia: past, present, and future. Chest 2008; 13:1267-1274
  3. Schenone AL, Cohen A, Patarroyo G et al. Therapeutic hypothermia after cardiac arrest: A systematic review/meta-analysis exploring the impact of expanded criteria and targeted temperature. Resuscitation 2016; 108: 102-110
  4. Guly H. History of accidental hypothermia. Resuscitation 2011; 82: 122-125
  5. Nolan JP, Neumar RW, Adrie C et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 2008; 79: 350-379
  6. Shankaran S. Neonatal encephalopathy: treatment with hypothermia. J Neurotrauma 2009; 26: 437-443
  7. Smith TL, Bleck TP. Hypothermia and neurologic outcome in patients following cardiac arrest: should we be hot to cool off our patients? Crit Care 2002; 6:377-380
  8. Alzaga AG, Cerdan M, Varon J. Therapeutic hypothermia. Resuscitation 2006; 70: 369-380
  9. Neumar RW, Nolan JP, Adrie C et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, Inter American Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452-2483
  10. Negovsky VA. The second step in resuscitation: the treatment of the "post-resuscitation disease". Resuscitation 1972; 1: 1-7
  11. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049-1062
  12. White BC, Grossman LI, Krause GS. Brain injury by global ischemia and reperfusion: a theoretical perspective on membrane dama